Complaint
| Product name | Taxol/Paclitaxel |
| Specification | 98%, 99.6% |
| Molecular formula | C47H51NO14 |
| Molecular weight | 853.92 |
| CAS No | 33069-62-4 |
| Origin | Yew Taxus plants dried roots, leaves and bark |
| Appearance | White crystalline powder |
| Related substances | ≤ 2.0% of total related substances |
| Organic volatile impurities | Complies with United States Pharmacopeia (USP) and the Chinese Pharmacopoeia (CP) Organic volatile impurities requirements. |
| Specific rotation | [α ] 20 D = -49.0 ° ~ 55.0 ° (10mg/mL solution in metha), anhydrous solvent dry product. |
| Moisture | ≤ 4.0% |
| Residue on ignition | ≤ 0.2% |
| Heavy metals | ≤ 0.002% |
| Microbial limit | ≤ 100cfu / g paclitaxel; Meet on Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella, Enterobacter sterility test requirements of people. |
Paclitaxe powder is a chemotherapy drug that is given as a treatment for some types of cancer. Paclitaxe powder is a mitotic inhibitor now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxe is also used for the prevention of restenosis.
1. Paclitaxe is a mitotic inhibitor drup used in the treatment of cancer.
2. Isolated the compound from the bark of the Pacific yew tree, Taxus brevifolia, and noted its antitumor activity in a broad range of rodent tumors.
3. Paclitaxe has since become an effective tool of doctors who treat patients with lung, ovarian, breast cancer, and advanced forms of Kaposi's sarcoma.
